Update on Fertility in Patients with Testicular Germ Cell Tumors
Presented by Pavel Škrobánek Moderated by Yue Che

Wednesday 21 October 2026,18:00-19:00 CEST

Presenter:

‍Dr. (MUDr.) Pavel Škrobánek,Department of Oncology, First Facultyof Medicine, Charles University and Thomayer University Hospital, Prague, CzechRepublicRadiation and clinical oncologist. Research interests: fertility and fertilitypreservation in men with testicular germ cell tumours (topic of PhD research);prostate cancer; digital remote monitoring of patient-reported treatmenttoxicity.

‍Moderator:‍

‍Dr. Yue Che, Urologist at University Hospital of CologneFocus areas: germ cell tumors, open and robotic surgery, uro-oncology

Testicular germ cell tumours (TGCTs) are the most common solid malignancy in young men, and with cure rates exceeding 95%, long-term survivorship, including fatherhood, has become a central goal of care. Many patients already have impaired spermatogenesis at diagnosis, and orchiectomy, platinum-based chemotherapy, radiotherapy and retroperitoneal lymph node dissection may further compromise fertility, ejaculatory and endocrine function. This webinar will review current evidence on semen quality and hormonal status at diagnosis, the dose-dependent effects of chemotherapy and radiotherapy on spermatogenesis and sperm DNA integrity, and the expected time course of recovery. Recent findings on sperm functional characteristics after chemotherapy will also be highlighted.

Register here

‍